Tag Archives: congress

Reflecting on July 2015: “The Ag Biotech Debate Was Front and Center”

U.S. Capitol Building - Congress

Agri-Pulse recently published an op-ed titled “The Biotechnology Riddle” by Marshall Matz which outlined how ag biotech was “front and center” in both executive and congressional affairs this past July. He guides readers through the actions taken by legislative officials to promote the benefits of biotechnology and scientific literacy. First on July 2nd the White House Office of Science and Technology Policy and the Office of U.S. Trade Representative issued an Executive Memorandum to “Modernize Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Seventy Nine House Members Express Concern with H.R. 9

Vote No on HR 9

House leaders made the decision earlier this month to remove patent reform legislation from the schedule for the remaining days before the August recess. While a vote is expected to occur sometime in September, House Majority Leader Kevin McCarthy made the decision to review and address many of the concerns that have been voiced by an array of industries that require the value of dependable and enforceable patents. In the words of Representative McCarthy, “I Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

Williams-headshot

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first time provided for biosimilar or interchangeable biological drug products.  But it was not until March 6, 2015, that the FDA approved the first biosimilar application – an application by Sandoz to market a version of Amgen’s NEUPOGEN® (filgrastrim) biologic drug product.  Nevertheless, there is still a question as to when Sandoz will be able to begin selling its drug product, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

BIO Coalition Submits Patent Reform Letter to Congress

medical_research

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen and ranking members of the House and Senate Judiciary Committees on December 10 regarding potential changes to the patent system. The coalition thanked members of the committee for their work to develop reforms which would prevent harmful patent enforcement practices, and once again reiterated their opposition to any legislation that would weaken the overall patent system. They also asked that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , ,

House Ag Subcommittee Considers the Societal Benefits of Biotechnology

wheat

“Organic farmers do not need to demonize conventional farmers, we are one agriculture,” opened Ranking Member. Kurt Schrader (OR-05). On July 9, 2014 at 10:00am, the House Committee on Agriculture, Subcommittee on Horticulture, Research, Biotechnology, and Foreign Agriculture held a public hearing “To consider the societal benefits of biotechnology”. Witnesses included: Dr. David Just, Professor, Co-Director, Cornell Center for Behavioral Economics in Child Nutrition Programs, Charles H. Dyson School of Applied Economics and Management, Cornell University, Ithaca, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,